Literature DB >> 15828584

High infection rates of Triatoma dimidiata are associated with low levels of Trypanosoma cruzi seroprevalence in Pedro Carbo, Ecuador. Use of a tc24 gene-based PCR approach.

A G Guevara1, E Garzón, C Bowen, X Córdova, E Gómez, A Ouaissi.   

Abstract

In control programs for vectorial transmission of Chagas' disease, conventional microscopic procedures are generally performed to determine baseline levels of infectivity of vectors. Reported here are data using Polymerase Chain Reaction in the detection of Trypanosoma cruzi in Triatoma dimidiata, one of the principal vectors of Chagas' disease in Ecuador. The microscopy and PCR techniques showed a high percentage of vector infection in Pedro Carbo, province of Guayas (Ecuador), with 44.16% and 46.13% positive insects, respectively. This contrasted with the very low Chagas seropositivity recorded (0.5%). Since T. dimidiata was the only vector of the Chagas' disease found in Pedro Carbo and looking at the vector behavior, our data suggest that despite the high T. dimidiata infection, the low Chagas seropositivity detected is closely associated with the epidemiological and ecological context of T. dimidiata in Pedro Carbo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15828584     DOI: 10.1051/parasite/2005121065

Source DB:  PubMed          Journal:  Parasite        ISSN: 1252-607X            Impact factor:   3.000


  2 in total

1.  House-level risk factors for Triatoma dimidiata infestation in Colombia.

Authors:  Gabriel Parra-Henao; Ángela Segura Cardona; Oscar Quirós-Gómez; Víctor Angulo; Neal Alexander
Journal:  Am J Trop Med Hyg       Date:  2014-10-27       Impact factor: 2.345

2.  First description of Trypanosoma cruzi human infection in Esmeraldas province, Ecuador.

Authors:  Ángel Guevara; Juan Moreira; Hipatia Criollo; Sandra Vivero; Marcia Racines; Varsovia Cevallos; Rosanna Prandi; Cynthia Caicedo; Francisco Robinzon; Mariella Anselmi
Journal:  Parasit Vectors       Date:  2014-08-06       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.